LifeMD, Inc. LFMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.99% | -3.16% | -3.70% | 0.01% | -0.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.99% | -3.16% | -3.70% | 0.01% | -0.73% |
| Cost of Revenue | -16.25% | -14.39% | -2.69% | 21.85% | 52.19% |
| Gross Profit | 0.68% | -1.29% | -3.85% | -2.92% | -6.81% |
| SG&A Expenses | 5.84% | 2.74% | -3.95% | -9.66% | -10.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 20.61% | 21.11% | 31.28% | 20.46% | 36.72% |
| Total Operating Expenses | 3.08% | 0.78% | -2.89% | -5.38% | -3.10% |
| Operating Income | -88.03% | -63.98% | -8.48% | 59.78% | 30.74% |
| Income Before Tax | -46.74% | -47.12% | -6.35% | 52.14% | 22.04% |
| Income Tax Expenses | -97.79% | -94.50% | -94.50% | -94.50% | -4.65% |
| Earnings from Continuing Operations | -40.78% | -39.53% | -1.50% | 53.71% | 21.45% |
| Earnings from Discontinued Operations | 236.58% | 313.41% | 597.58% | 1,711.89% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 101.30% | 81.23% | 23.65% | -130.63% | -113.98% |
| Net Income | 95.65% | 101.03% | 137.65% | 166.66% | 47.37% |
| EBIT | -88.03% | -63.98% | -8.48% | 59.78% | 30.74% |
| EBITDA | -343.87% | -256.69% | -102.42% | 43.12% | 69.95% |
| EPS Basic | 78.58% | 82.64% | 111.99% | 138.94% | 46.55% |
| Normalized Basic EPS | -99.43% | -77.81% | -31.48% | 38.50% | 54.97% |
| EPS Diluted | 78.36% | 82.73% | 111.67% | 138.41% | 46.22% |
| Normalized Diluted EPS | -99.43% | -77.81% | -31.48% | 38.50% | 54.97% |
| Average Basic Shares Outstanding | 8.06% | 9.49% | 9.49% | 9.53% | 10.41% |
| Average Diluted Shares Outstanding | 8.06% | 9.49% | 9.49% | 9.53% | 10.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -21.99% | 97.78% | 3.66% | 2.50% | -0.90% |